AVIGEN LTD
Company number 16211696 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£262,466
Balance sheet as at 2026-01-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2025-01-27
- Employees
- 3 (2026 accounts)
- Registered office
- 58 Wood Lane, White City, Incubator, Level 2, Phase C, Lab 6, London, England, W12 7RZ
- Postcode
- W12 7RZ
- Capital
- 1 GBP
- Accounts category
- Micro
Accounts
- Last made up to
- 2026-01-31
- Next due by
- 2027-10-31
- Financial year end
- 31 January
Confirmation statement
- Last statement dated
- 2026-01-26
- Next due by
- 2027-02-09
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current
Contact details
- Website
- avigen.co.uk
Avigen provides analytical immunotherapy and cell therapy R&D services using avidity to identify potent and safe lead drug candidates faster.
Competitors London
This company ranks 47 among research and experimental development on biotechnology in London.